dr. wilson on long-term data with dabrafenib plus trametinib in melanoma
Published 7 years ago • 270 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
1:03
dr. wilson on choosing between braf/mek therapies for patients with melanoma
-
2:33
dr. sullivan discusses role of dabrafenib plus trametinib in melanoma
-
1:26
dr. nathan on long-term outcomes with dabrafenib/trametinib in braf v600-mutant melanoma
-
1:31
dr. daud on dabrafenib/trametinib vs immunotherapy in melanoma
-
2:51
combi-ad: long-term follow-up of dabrafenib and trametinib in braf-mutated melanoma
-
8:12
what is the best way to prevent and detect melanoma?
-
17:08
what happens when you have a disease doctors can't diagnose | jennifer brea
-
4:36
practical experience with dabrafenib/trametinib in ncslc
-
0:30
dr. postow on fda approval of adjuvant dabrafenib plus trametinib in braf-mutant melanoma
-
1:19
dr. robert on potential of dabrafenib/trametinib in melanoma brain metastases
-
0:44
dr. michael rotkowitz on dabrafenib and trametinib combination side effects
-
2:11
dr. georgina long on dabrafenib and trametinib in braf-mutated melanoma
-
1:24
dr. algazi on benefit of continuous dabrafenib/trametinib dosing in braf melanoma
-
2:19
dr. robert on 5-year analysis of dabrafenib/trametinib in braf v600-mutant melanoma
-
1:46
dr. weber on dabrafenib/trametinib approval for melanoma
-
34:05
targeted & immunologic therapy in advanced melanoma by dr. wilson h. miller, jr.
-
4:08
updates from combi-ad: dabrafenib and trametinib for melanoma
-
1:08
dr. weber on dabrafenib/trametinib versus vemurafenib/cobimetinib in melanoma
-
0:18
copy of dr. weber on the fda approval of adjuvant dabrafenib/trametinib in braf-mutant melanoma
-
1:40
dr. robert on the phase iii combi-v study in braf-mutant melanoma
-
1:33
dr. robert on next steps following the phase iii combi-v study in melanoma
-
11:06
esmo 2019: dr. hamid discusses exciting immunotherapy data in melanoma